Table 2 Baseline sleep study results in the control and treatment groups and effects of NIV treatment on sleep architecture and gas exchange during sleep in the treatment group
LTOTNIV + LTOTNIV + LTOT
BaselineBaselineNIV treatment
Total sleep time (min)243 (226 to 260)249 (231 to 267)252 (234 to 271)
Sleep efficiency (%)61.0 (56.8 to 65.2)59.6 (55.4 to 63.8)59.7 (55.7 to 63.7)
% NREM85.0 (83.0 to 87.0)86.7 (84.6 to 88.8)82.6 (80.4 to 84.8)*
% REM15.2 (13.2 to 17.3)13.3 (11.2 to 15.4)17.5 (15.3 to 19.7)*
Apnoea-hypopnoea index (events/h)6.1 (4.8 to 7.5)4.5 (3.4 to 5.6)2.8 (1.6 to 4.0)*
Tcco2 sleep increase (mm Hg)18.8 (16.5 to 21.0)16.5 (14.7 to 18.3)12.6 (10.9 to 14.3)*
IPAP (cm H2O)12.9 (12.5 to 13.4)
EPAP (cm H2O)5.1 (4.8 to 5.3)
  • Values are mean (95% CI).

  • *p<0.05 compared with corresponding baseline values.

  • EPAP, expiratory partial airway pressure; IPAP inspiratory partial airway pressure; LTOT, long-term oxygen therapy; NIV + LTOT, nocturnal non-invasive ventilation plus long-term oxygen therapy; % NREM, non-rapid eye movement sleep expressed as a percentage of total sleep time; % REM, rapid eye movement sleep expressed as a percentage of total sleep time; Tcco2, transcutaneous partial pressure of carbon dioxide.